Seattle Children’s Launches 2-Pronged CAR T-Cell Therapy Trial in Refractory Acute Lymphoblastic Leukemia – Immuno-Oncology News
|
Seattle Children's Launches 2-Pronged CAR T-Cell Therapy Trial in Refractory Acute Lymphoblastic Leukemia
Immuno-Oncology News Seattle Children's Hospital has launched a new clinical trial, PLAT-05 (NCT03330691), and is currently recruiting participants to test a new CAR T-cell immunotherapy targeting two proteins expressed on cancer cells of certain patients with relapsed or … |
